A Prospective Double-blind Trial of a Low Molecular Weight Heparin Once Daily Compared with Conventional Low-dose Heparin Three Times Daily to Prevent Pulmonary Embolism and Venous Thrombosis in Patients with Hip Fracture | Publicación